Literature DB >> 21092071

Significance of periductal Langerhans cells and biliary epithelial cell-derived macrophage inflammatory protein-3α in the pathogenesis of primary biliary cirrhosis.

Kenichi Harada1, Shinji Shimoda, Hiroko Ikeda, Mayumi Chiba, Maylee Hsu, Yasunori Sato, Mio Kobayashi, Xiang Shan Ren, Hajime Ohta, Satomi Kasashima, Atsuhiro Kawashima, Yasuni Nakanuma.   

Abstract

BACKGROUND/AIMS: To clarify the primary biliary cirrhosis (PBC)-specific antigen-presenting mechanism, we examined the distribution and phenotypic characteristics of infiltrating dendritic cells (DCs) with respect to bile ducts and the mechanism of migration in terms of the periductal cytokine milieu and biliary innate immunity. METHODS AND
RESULTS: Immunohistochemistry using liver sections from patients with PBC and controls revealed that blood dendritic cell antigen (BDCA)-2(+) plasmacytoid DCs were found mainly in the portal tracts in PBC and the controls, but their distribution was not related to bile ducts. BDCA-1(+) and CD19(-) myeloid DCs were also found in portal tracts in PBC and the controls and, in particular, Langerin+Langerhans cells (LCs) were dominantly scattered around or within biliary epithelial layers of the damaged bile ducts in PBC. Moreover, experiments with cultured human biliary epithelial cells (BECs) showed that an LC-attracting chemokine, macrophage inflammatory protein-3α, was produced by BECs in the response to cytokines [interleukin (IL)-1β, tumour necrosis factor-α and IL-17] and pathogen-associated molecular patterns.
CONCLUSIONS: LCs existing around or within biliary epithelial layers are important as periductal antigen-presenting cells in PBC and the migration of LCs into bile ducts is closely associated with the periductal cytokine milieu and biliary innate immunity in PBC.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21092071     DOI: 10.1111/j.1478-3231.2010.02367.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  11 in total

Review 1.  Advances in cholangiocyte immunobiology.

Authors:  Gaurav Syal; Michel Fausther; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-06       Impact factor: 4.052

Review 2.  Liver immunology.

Authors:  Dimitrios P Bogdanos; Bin Gao; M Eric Gershwin
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

3.  Cholangiopathy with respect to biliary innate immunity.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2011-08-11

Review 4.  Sex differences associated with primary biliary cirrhosis.

Authors:  Daniel S Smyk; Eirini I Rigopoulou; Albert Pares; Charalambos Billinis; Andrew K Burroughs; Luigi Muratori; Pietro Invernizzi; Dimitrios P Bogdanos
Journal:  Clin Dev Immunol       Date:  2012-05-30

Review 5.  Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases.

Authors:  Haiyan Zhang; Francesca Bernuzzi; Ana Lleo; Xiong Ma; Pietro Invernizzi
Journal:  Mediators Inflamm       Date:  2015-06-04       Impact factor: 4.711

Review 6.  The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review.

Authors:  Wen-Tao Ma; Fei Gao; Kui Gu; De-Kun Chen
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

7.  Single-Cell Characterization of Hepatic CD8+ T Cells in a Murine Model of Primary Biliary Cholangitis.

Authors:  Yichen Han; Zhen-Hua Bian; Si-Yu Yang; Cheng-Bo Wang; Liang Li; Yan-Qing Yang; Aftab A Ansari; M Eric Gershwin; Xiaofeng Zeng; Zhe-Xiong Lian; Zhi-Bin Zhao
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

8.  IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.

Authors:  Stephanie Stein; Lara Henze; Tobias Poch; Antonella Carambia; Till Krech; Max Preti; Fenja Amrei Schuran; Maria Reich; Verena Keitel; Romina Fiorotto; Mario Strazzabosco; Lutz Fischer; Jun Li; Luisa Marie Müller; Jonas Wagner; Nicola Gagliani; Johannes Herkel; Dorothee Schwinge; Christoph Schramm
Journal:  J Hepatol       Date:  2020-11-13       Impact factor: 25.083

Review 9.  Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.

Authors:  Debora Maria Giordano; Claudio Pinto; Luca Maroni; Antonio Benedetti; Marco Marzioni
Journal:  Int J Mol Sci       Date:  2018-10-01       Impact factor: 5.923

10.  Single cell sequencing analysis identifies genetics-modulated ORMDL3+ cholangiocytes having higher metabolic effects on primary biliary cholangitis.

Authors:  Bingyu Xiang; Chunyu Deng; Fei Qiu; Jingjing Li; Shanshan Li; Huifang Zhang; Xiuli Lin; Yukuan Huang; Yijun Zhou; Jianzhong Su; Mingqin Lu; Yunlong Ma
Journal:  J Nanobiotechnology       Date:  2021-12-06       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.